广谱
化学
立体化学
药理学
癌症研究
组合化学
生物
作者
Zhengshui Xu,Changchun Ye,Xingjie Wang,Ranran Kong,Zilu Chen,Jing Shi,Xin Chen,Shiyuan Liu
标识
DOI:10.1080/14756366.2024.2409771
摘要
A series of triazolopyridine-based dual JAK/HDAC inhibitors were rationally designed and synthesised by merging different pharmacophores into one molecule. All triazolopyridine derivatives exhibited potent inhibitory activities against both targets and the best compound 4-(((5-(benzo[
科研通智能强力驱动
Strongly Powered by AbleSci AI